Press release
Acute Care Hospital Bed and Stretcher Market Projections $9.32 Billion by 2034 | Fact.MR
True According to a recently released study report by MR, a provider of competitive intelligence and market research, the global Acute Care Hospital Bed And Stretcher Market (急性期病院用ベッドおよび担架市場) is expected to reach US$ 8.08 billion by 2024. From 2024 to 2034, the demand for stretchers and acute care hospital beds is expected to rise globally at a 1.4% CAGR. Stretchers and acute care hospital beds are in greater demand as a result of the growing population and rising costs for healthcare infrastructure and equipment. Many hospitals invest in cutting-edge, effective patient care equipment to guarantee that patients receive high-quality care.For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9123
Key Segments of Acute Care Hospital Bed and Stretcher Industry Research Report:
Elderly people need more specialized medical treatment regularly as they are prone to many disorders due to their weaker immune systems. Acute care stretchers and beds are adapted to match the specific requirements of elderly people. Further, with growing cases of chronic diseases, requirements for continued medical treatment and hospitalization are increasing for the care and management of patients.
Development of technologically advanced acute care hospital beds and stretchers with improved features, including integration with several other medical devices, patient monitoring, and computerized controls is forecasted to open up lucrative opportunities for players.
Key Takeaway from Market Study:
The global acute care hospital bed and stretcher market is forecasted to end up at a valuation of US$ 9.32 billion by 2034.
Revenue from the sales of acute care hospital beds and stretchers is projected to rise at 1.4% CAGR from 2024 to 2034.
Sales of acute care hospital beds and stretchers in the United States are pegged at US$ 1.61 billion in 2024.
Latin America is predicted to hold 11.9% share of global market revenue in 2024.
Revenue from acute care hospital beds and stretchers in Brazil is projected to reach US$ 745.17 million by 2034.
"Growing geriatric population along with rising prevalence of chronic diseases across the globe is predicted to stimulate demand for acute care hospital beds and stretchers as a part of effective healthcare practices," says a Fact.MR analyst.
Asia Pacific to Lead Global Market Growth:
Several countries from Asia Pacific, including China, India, etc. are forecasted to contribute to increased demand for acute care hospital beds and stretchers because of the rising prevalence of chronic diseases. In addition, the presence of many prominent players in the regional countries is also predicted to contribute to market revenue.
Key Market Players:
Leading manufacturers of acute care hospital beds and stretchers are Invacare Corporation, Stryker Corporation, Hill-Rom Holdings Inc., LINET, Paramount Bed Holdings Co., Ltd., Getinge AB, Howard Wright Limited, and Midmark Corp.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9123
By 2034, beds are expected to constitute 86.1% of the global market revenue. Acute care beds, designed for patient accommodation during illness, labor management, and specific injury treatments, play a prominent role. Diverse bed types cater to patient needs, such as tilting beds supporting intensive care unit (ICU) staff in patient care and repositioning for accelerated recovery.
Ensuring optimal protection and comfort, beds aid patients in standing and sitting up swiftly, promoting successful recovery and yielding economic and health benefits. Mobilization beds effectively fulfill this purpose.
Hospitals are anticipated to command a 72.1% share of the global market revenue by 2034. Hospitals prioritize upgrading to advanced acute care hospital beds and stretchers, enhancing functionality and patient care. The replacement of older equipment with specialized and more efficient units is poised to drive increased demand.
Healthcare providers are directing investments toward expanding specialized units like neonatal care, cardiac care, and intensive care, necessitating customized beds and stretchers tailored to specific patient requirements.
Browse Full Report @ https://www.factmr.com/report/acute-care-hospital-bed-and-stretcher-market
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the acute care hospital bed and stretcher market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights into the market based on product type (beds, stretchers) and end user (hospitals, ambulatory surgical centers, and specialty clinics), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).
Checkout More Related Studies Published by Fact.MR Research:
Embolotherapy Market:
https://www.factmr.com/report/embolotherapy-market
Atherectomy Device Market:
https://www.factmr.com/report/atherectomy-device-market
Holter Monitoring System Market:
https://www.factmr.com/report/holter-monitoring-system-market
Oral Solid Dosage Contract Manufacturing Market:
https://www.factmr.com/report/oral-solid-dosage-contract-manufacturing-market
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Care Hospital Bed and Stretcher Market Projections $9.32 Billion by 2034 | Fact.MR here
News-ID: 3504410 • Views: …
More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need…

Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in…

Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising…

Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035.
The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…